Related Experiment Video
Updated: May 20, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Optimal design of multi-arm multi-stage trials
1Hub for Trials Methodology Research, MRC Biostatistics Unit, Cambridge, UK. james.wason@mrc-bsu.cam.ac.uk
Multi-arm multi-stage (MAMS) trials improve drug development efficiency. This study proposes a new method for optimal MAMS trial design, minimizing sample size while maintaining statistical power and error rates.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Pharmaceutical Research
Background:
- Drug development faces uncertainty in selecting effective treatments.
- Multi-arm multi-stage (MAMS) trials offer efficiency gains over traditional separate trials.
- MAMS trials enable shared control groups, early dropping of ineffective treatments, and early stopping for efficacy.
Purpose of the Study:
- To discuss and propose an optimal design for MAMS trials.
- To develop a method for efficiently finding optimal design parameters.
- To evaluate the impact of control group allocation on MAMS trial efficiency.
Main Methods:
- Proposed a method combining rapid design evaluation with stochastic search for optimal parameters.
- Investigated various potential MAMS trial designs, including those for Phase II trials.
- Analyzed the effect of allocating more patients to the control group.
Main Results:
- The proposed method efficiently identifies optimal MAMS trial designs.
- Optimal allocation to the control group is greater than 1:1 but less than previously suggested.
- Increased allocation to the control group yields only small efficiency gains.
Conclusions:
- The developed method facilitates the efficient design of MAMS trials.
- Current practices for control group allocation in MAMS trials may be suboptimal.
- Further research can refine MAMS trial efficiency through optimized design and allocation strategies.
More Related Videos
13:54A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
Published on: August 18, 2023
20:24Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Methods of Medium Optimization
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioavailability Study Design: Single Versus Multiple Dose Studies
Dosage Regimens: Designs and Approaches